Microglia in Cancer: For Good or for Bad?

Adv Exp Med Biol. 2016:949:245-261. doi: 10.1007/978-3-319-40764-7_12.

Abstract

Glioblastoma is a malignant tumor of astrocytic origin that is highly invasive, proliferative and angiogenic. Despite current advances in multimodal therapies, such as surgery, radio- and chemotherapy, the outcome for patients with glioblastoma is nearly always fatal. The glioblastoma microenvironment has a tremendous influence over the tumor growth and spread. Microglia and macrophages are abundant cells in the tumor mass. Increasing evidence indicates that glioblastoma recruits these cell populations and signals in a way that microglia and macrophages are subverted to promote tumor progression. In this chapter, we discuss some aspects of the interaction between microglia and glioblastoma, consequences of this interaction for tumor progression and the possibility of microglial cells being used as therapeutic vectors, which opens up new alternatives for the development of GBM therapies targeting microglia.

Keywords: Central nervous system; Glioblastoma; Microglia; Therapy.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use
  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / therapy
  • Cell Communication / drug effects
  • Cell Communication / radiation effects
  • Cytokines / genetics
  • Cytokines / metabolism
  • Dacarbazine / analogs & derivatives
  • Dacarbazine / therapeutic use
  • ErbB Receptors / genetics
  • ErbB Receptors / metabolism
  • Gamma Rays / therapeutic use
  • Gene Expression Regulation, Neoplastic*
  • Glioblastoma / genetics
  • Glioblastoma / metabolism*
  • Glioblastoma / pathology
  • Glioblastoma / therapy
  • Humans
  • Macrophages / metabolism*
  • Macrophages / pathology
  • Microglia / metabolism*
  • Microglia / pathology
  • Oligodeoxyribonucleotides / therapeutic use
  • Signal Transduction
  • Temozolomide
  • Treatment Failure
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents, Alkylating
  • CPG-oligonucleotide
  • Cytokines
  • Oligodeoxyribonucleotides
  • Dacarbazine
  • EGFR protein, human
  • ErbB Receptors
  • Temozolomide